Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Care”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06201234
What this trial is testing

Evaluating the Addition of Elacestrant (Oral SERD) to Olaparib (PARP-inhibitor) in Patients With Advanced/Metastatic HR+/HER2- Breast Cancer

Who this might be right for
Hormone Receptor Positive HER-2 Negative Breast CancerAdvanced or Metastatic Breast CancerBRCA1 Mutation+1 more
GBG Forschungs GmbH 176
Not applicableStudy completedNCT02862730
What this trial is testing

Four Way Crossover Closed Loop With Exercise Detection

Who this might be right for
Type 1 Diabetes
Oregon Health and Science University 25
Not applicableStudy completedNCT00322166
What this trial is testing

The FREEDOM Study: a Randomised Controlled Trial of Sunlight and Calcium in Older People

Who this might be right for
Accidental Falls
University of Sydney 600
Not applicableStudy completedNCT02003417
What this trial is testing

Cardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone Therapy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 101
Post-approval studies (Phase 4)Study completedNCT03443271
What this trial is testing

Effect of TAP Block on Stress Hormones

Who this might be right for
Abdominal HysterectomyPostoperative Pain
Aga Khan University 50
Not applicableStudy completedNCT05122377
What this trial is testing

RWE About QOL and Compliance of Patients With OFS in China

Who this might be right for
Breast CancerQuality of LifeHormone Receptor-positive Breast Cancer
Fudan University 562
Testing effectiveness (Phase 2)Study completedNCT02015559
What this trial is testing

Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerOral Complications+5 more
Jonsson Comprehensive Cancer Center 61
Large-scale testing (Phase 3)Looking for participantsNCT06350825
What this trial is testing

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

Who this might be right for
Metastatic Prostate CancerTherapy, Directly Observed
The First Affiliated Hospital with Nanjing Medical University 200
Large-scale testing (Phase 3)Ended earlyNCT00908531
What this trial is testing

Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer

Who this might be right for
Operable Breast Neoplasms
Danish Breast Cancer Cooperative Group 123
Large-scale testing (Phase 3)Not Yet RecruitingNCT07813351
What this trial is testing

PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours

Who this might be right for
Acromegaly Due to Pituitary AdenomaCushing's DiseasePituitary Adenoma
University College, London 82
Not applicableStudy completedNCT03873675
What this trial is testing

Parathyroid Hormone Kinetics During CRRT

Who this might be right for
Critical IllnessMulti Organ FailureRenal Failure+2 more
Uniwersytecki Szpital Kliniczny w Opolu 30
Not applicableStudy completedNCT05465408
What this trial is testing

Culturally Aware AET Non-Initiation Intervention

Who this might be right for
Breast CancerSurvivorshipTreatment Compliance+2 more
Massachusetts General Hospital 35
Not applicableStudy completedNCT06151418
What this trial is testing

Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces

Who this might be right for
Prostatic Neoplasms
Pfizer 2,313
Not applicableActive Not RecruitingNCT05503160
What this trial is testing

Primary Hormone-sensitive Breast Cancer: Need-driven Health Care Improvement by Patient-centred Digital Application

Who this might be right for
New Healthcare Approach
Technical University of Munich 400
Not applicableEnded earlyNCT01277926
What this trial is testing

Patterns of Care in Hormone-receptor Positive, Advanced Breast Cancer

Who this might be right for
Breast Cancer
AstraZeneca 7
Not applicableNot Yet RecruitingNCT06999291
What this trial is testing

Ovarian Reserve in Intensive Care Patients

Who this might be right for
Anti-Mullerian Hormone Deficiency
Haseki Training and Research Hospital 75
Not applicableStudy completedNCT04590976
What this trial is testing

Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research

Who this might be right for
Prostate Cancer MetastaticRadiotherapy Side EffectSurgery+4 more
Imperial College London 320
Not applicableUnknownNCT06353555
What this trial is testing

Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage

Who this might be right for
Intracerebral HemorrhageLow T3 SyndromeNeurocritical Care+1 more
Peking Union Medical College Hospital 100
Post-approval studies (Phase 4)Study completedNCT03355157
What this trial is testing

A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study).

Who this might be right for
Metastatic Breast Cancer
GBG Forschungs GmbH 130
Testing effectiveness (Phase 2)Study completedNCT02675231
What this trial is testing

Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Hormone Receptor Positive Breast CancerHER-2 Positive Breast Cancer
Eli Lilly and Company 237
Next Page